Intestinal Metaplasia of Gastric Mucosa
8
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
The GAstric Precancerous Conditions Study
Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score
Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program
Validation the Artificial Intelligence System for Automatic Evaluation of the Extent of Intestinal Metaplasia
Intestinal Metaplasia Cohort for Gastric Cancer Prediction
Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial Intelligence
Artificial Intelligence Confocal Laser Endomicroscopy for Real-time Assessment of Gastric Cancer Risk.
Novel Approach to Surveillance of Gastric Lesions